ofloxacin has been researched along with itraconazole in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 6 (42.86) | 29.6817 |
| 2010's | 7 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Fallen, H; Müller, M; Zöller, L | 1 |
| Borlenghi, E; Capucci, MA; Carosi, GP; Cattaneo, C; Franco, F; Grazioli, L; Pan, A; Quaresmini, G; Rossi, G | 1 |
| Azar, DT; Green, LK; Kocatürk, T; Pineda, R | 1 |
| Bashir, G; Hussain, W; Rizvi, A | 1 |
| Chernin, L; Dalal, P; Hostoffer, R; Swender, D; Tcheurekdjian, H | 1 |
| Datau, EA | 1 |
1 review(s) available for ofloxacin and itraconazole
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
13 other study(ies) available for ofloxacin and itraconazole
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
[Pulmonary aspergillosis in an immunocompetent female patient].
Topics: Administration, Inhalation; Aspergillosis; Aspergillus fumigatus; Azlocillin; Bronchi; Bronchoscopy; Drug Therapy, Combination; Female; Gentamicins; Humans; Immunocompetence; Itraconazole; Lung Diseases, Fungal; Medical Waste Disposal; Middle Aged; Nystatin; Ofloxacin; Oxacillin; Risk Factors; Sputum; Tetracycline | 1994 |
Usefulness of the MSG/IFICG/EORTC diagnostic criteria of invasive pulmonary aspergillosis in the clinical management of patients with acute leukaemia developing pulmonary infiltrates.
Topics: Acute Disease; Adult; Aged; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Ciprofloxacin; Female; Humans; Itraconazole; Leukemia; Male; Middle Aged; Models, Theoretical; Ofloxacin; Practice Guidelines as Topic; Reproducibility of Results; Treatment Outcome | 2007 |
Post-LASIK epithelial dendritic defect associated with Alternaria.
Topics: Alternaria; Amphotericin B; Antifungal Agents; Combined Modality Therapy; Corneal Ulcer; Debridement; Drug Combinations; Drug Therapy, Combination; Epithelium, Corneal; Eye Infections, Fungal; Female; Humans; Itraconazole; Keratomileusis, Laser In Situ; Keratoplasty, Penetrating; Middle Aged; Mycoses; Ofloxacin; Polymyxin B; Postoperative Complications; Trimethoprim | 2007 |
Bipolaris hawaiiensis keratomycosis and endophthalmitis.
Topics: Agriculture; Anti-Bacterial Agents; Antifungal Agents; Ascomycota; Cornea; Corneal Injuries; Corneal Ulcer; Endophthalmitis; Eye Evisceration; Humans; Hyphae; Itraconazole; Male; Middle Aged; Natamycin; Ofloxacin; Photophobia; Vision, Low | 2009 |
Histoplasmosis in the olecranon bursa of a patient with idiopathic CD4 lymphocytopenia.
Topics: Adult; Histoplasma; Histoplasmosis; Humans; Itraconazole; Male; Ofloxacin; Olecranon Process; T-Lymphocytopenia, Idiopathic CD4-Positive; Trimethoprim, Sulfamethoxazole Drug Combination | 2011 |
A patient with allergic bronchopulmonary mycosis caused by Aspergillus fumigatus and Candida albicans.
Topics: Ambroxol; Anti-Bacterial Agents; Antifungal Agents; Aspergillus fumigatus; Bronchodilator Agents; Budesonide; Candida albicans; Candidiasis; Ethanolamines; Expectorants; Fluconazole; Formoterol Fumarate; Glucocorticoids; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Lung Diseases, Fungal; Male; Methylprednisolone; Middle Aged; Ofloxacin | 2012 |